EMILY FRITTER: Open Payments
NPI 1285329037 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 45 payments from 16 companies in 2025. Trend: 2023 $51 · 2024 $39 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $315 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $179 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $137 |
| ABBVIE INC. | 5 | $111 |
| Corcept Therapeutics | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
Products named: Wegovy, XIFAXAN, INGREZZA, Korlym, EPKINLY, FARXIGA, BREZTRI, JARDIANCE.
Industry payments across NC — which companies pay providers there.
